Table 2.

Clinical outcomes after liver transplantations in the pediatric patients with biliary atresia.

Outcome	N = 145
Patient survival, N (%)	139 (95.8%)
Median patient survival time (years)	12.33 (8.43–16.48)
Expire after LT, N (%)	6 (4.1%)
Post-op. complications	4/6 (66.7%)
Acute rejection	1/6 (16.7%)
Others	1/6 (16.7%)
Median time interval to expire (months)	2.80 (1.31–10.42)
Graft survival, N (%)	132 (91.0%)
Median graft survival times (years)	12.10 (6.36–16.25)
Re-liver transplantation, N (%)	7 (4.8%)
Median time interval to re-LT (months)	9.23 (5.91–74.5)
Cholangitis	24 (16.6%)
With bile duct stricture	7 (4.8%)
Single event	15/24 (62.5%)
Multiple events	9/24 (37.5%)
Rejection	44 (30.3%)
Single event	31 (70.5%)
Multiple events	13 (29.5%)
Other postoperative complications
PTLD	16 (11.0%)
Portal vein stenosis	22 (15.2%)
Bile duct stricture	9 (6.2%)
Hepatic artery stenosis	4 (2.8%)
Thrombosis	6 (4.1%)
– Hepatic artery	2
– Portal vein	3
– Hepatic vein	1
Bleeding	3 (2.1%)
Infection	14 (9.7%)
Bowel perforation, anastomosis leakage	6 (4.1%)

Values are expressed as n (percentage) or median (interquartile range).